secwatch.observer — SEC 8-K summary
======================================

Issuer:     SAB Biotherapeutics, Inc. (SABS)
CIK:        0001833214
Form:       8-K
Filed at:   2025-02-05T23:59:59+00:00
Accession:  0000950170-25-014627
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SAB Biotherapeutics enters 5-year lease for Sioux Falls lab/office space from Sanford Health
--------------------------------------------------------------------------------

- Leases 21,014 sq ft at 2301 E 60th St N, Sioux Falls, SD; term effective Feb 1, 2025 through Dec 31, 2029.
- Annual rent $601,630.82 ($28.63/sq ft), paid monthly at $50,135.90; January 2025 rent paid under prior lease.
- Annual rent escalates by greater of 2% or CPI starting Jan 1, 2026; either party may terminate with 90 days' notice.
- Tenant responsible for maintenance and repairs; Landlord pays utilities, taxes, and base-building maintenance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1833214/000095017025014627/0000950170-25-014627-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1833214/000095017025014627/sabs-20250130.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-014627

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer